Financing Quarterly Statistics, Q2 2023

A Look At Financing Activity Across The Biopharma, Medical Device And In Vitro Diagnostics Industries, April-June 2023

During Q2, biopharmas brought in an aggregate $23.8bn in financing and device company fundraising totaled $2.4bn; while in vitro diagnostic firms and research tools players raised $684m.

Qstats Image 1
• Source: Alamy

Biopharma financing during the second quarter of 2023 totaled $23.8bn from 268 deals. The venture financings category made up the greatest proportion (27%) of the aggregate Q2 financing dollars (see Exhibit 1), with 91 early- and late-stage VC rounds together totaling $6.4bn.

There were 67 biopharmas together raising $3.4bn (14% of the total Q2 dollars) through early-stage rounds and 24 companies bringing...

More from Deal-Making

More from In Vivo